Advances of study on PPARgamma/PPARgamma ligand in hematologic malignancies / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 1592-1596, 2009.
Article
in Chinese
| WPRIM
| ID: wpr-328593
ABSTRACT
Recently, along with the thorough investigation on the gene and molecular biology of peroxisome proliferators activated receptorgamma (PPARgamma), the therapeutic effects of PPARgamma ligand and its potential mechanism were gradually recognized. PPARgamma will probably become a new target of oncotherapy and is now extensively followed by researchers. This review focuses the advances of study on PPARgamma distribution in tissue, its function, its ligand in relationship with hematologic malignancies including acute myeloid leukemia, acute lymphocytic leukemia, chronic myeloid leukemia, lymphoma, multiple myeloma and so on.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Hematologic Neoplasms
/
PPAR gamma
/
Ligands
/
Metabolism
Limits:
Humans
Language:
Chinese
Journal:
Journal of Experimental Hematology
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS